Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

PLoS One. 2015 Oct 9;10(10):e0140623. doi: 10.1371/journal.pone.0140623. eCollection 2015.
No abstract available

Publication types

  • Published Erratum